The effect of estrogen replacement on early Parkinson's disease.
about
Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaineGonadal steroids differentially modulate neurotoxicity of HIV and cocaine: testosterone and ICI 182,780 sensitive mechanismSex and Gender Differences in Central Nervous System-Related DisordersSex differences in Parkinson's diseaseNo sex differences in use of dopaminergic medication in early Parkinson disease in the US and Canada - baseline findings of a multicenter trial.Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines.Risk of Parkinson's disease after tamoxifen treatment.Parkinson's disease in women: a call for improved clinical studies and for comparative effectiveness research.Estrogen receptor activation and tardive dyskinesia.Neuroprotective role of estrogen upon methamphetamine and related neurotoxins within the nigrostriatal dopaminergic system.Role of calbindin-D28K in estrogen treatment for Parkinson's disease.Estrogen-related and other disease diagnoses preceding Parkinson's diseaseMembrane estrogen receptors activate the metabotropic glutamate receptors mGluR5 and mGluR3 to bidirectionally regulate CREB phosphorylation in female rat striatal neuronsHysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study.Oestrogen receptors enhance dopamine neurone survival in rat midbrain.Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease.Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases.Antioxidants as treatment for neurodegenerative disorders.Are gonadal steroid hormones involved in disorders of brain aging?Estrogen receptor agonists for attenuation of neuroinflammation and neurodegeneration.Pregnancy in multiple system atrophy: a case reportPeripheral vs. Central Sex Steroid Hormones in Experimental Parkinson's Disease.Male/Female differences in neuroprotection and neuromodulation of brain dopamineEstrogen receptor beta in health and disease.Variants in estrogen-related genes and risk of Parkinson's diseaseGenetic findings in Parkinson's disease and translation into treatment: a leading role for mitochondria?Aging of brain: role of estrogen.Enhanced striatal β1-adrenergic receptor expression following hormone loss in adulthood is programmed by both early sexual differentiation and puberty: a study of humans and rats.Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease.Estrogen, testosterone, and sequential movement in men.The role of estrogen in the treatment of men with schizophrenia.The Effects of Puerariae Flos on Stress-induced Deficits of Learning and Memory in Ovariectomized Female Rats.Evidence for gender differences in cognition, emotion and quality of life in Parkinson's disease?Estrogen agonist genistein differentially influences the cognitive and motor disorders in an ovariectomized animal model of ParkinsonismSteroids-dopamine interactions in the pathophysiology and treatment of CNS disorders.Genetic variability in estrogen disposition: Potential clinical implications for neuropsychiatric disorders.Oestrogen receptors and signalling pathways: implications for neuroprotective effects of sex steroids in Parkinson's disease.Movement disorders in women: a review.Ginsenoside Rg1 protects against 6-OHDA-induced neurotoxicity in neuroblastoma SK-N-SH cells via IGF-I receptor and estrogen receptor pathways.Oestrogen receptor subtype-specific repression of calpain expression and calpain enzymatic activity in neuronal cells--implications for neuroprotection against Ca-mediated excitotoxicity.
P2860
Q24796371-591953C6-86B3-455E-86DE-57CA9817D23FQ24813383-CCF12B33-44BC-4F76-B390-B4A6610C4FABQ26744569-8EDC95BC-96FF-41B9-A445-612E477E22B3Q27025107-A1887D36-0438-4265-BD27-92E93C962436Q30409132-ED332626-1BEA-4466-A1B5-BE3D79E0DB27Q30478476-CB0D6F3E-2070-412E-BF66-6AE4284F7B14Q33552831-49443381-E33A-4AA1-9C0B-61F12D062FFBQ33874635-65A442F9-6EC6-4C2C-A24C-AD7B04116C1AQ33898374-76F2AB5A-0D9A-403E-8AE0-44A109C77187Q34086081-9DF28999-113D-4ACA-858D-855E161D68D7Q34095326-9258F8ED-ACE7-4907-B5C3-B361CC54DD44Q34144121-F171FDDB-73F8-46B0-9169-F649904865C8Q34172589-FF9357DB-F88F-458E-ACE0-432F0F6A8049Q34464847-F70576F1-9ACC-4EC4-9574-24F6F70F7503Q34483979-CCE33488-F816-4DEA-86DD-9D23282D9C9DQ34523361-71D29446-31F3-4F31-9383-DB34A0297BDEQ34784469-2C946592-A7CA-4127-A528-B561DEB99B23Q34974866-41F51F30-A75F-41C7-963D-81FA1315B7FAQ35185545-FB237580-3ED1-43CA-83B3-DCB484854334Q35230714-F1C1DA48-2D02-4262-A29C-60F4AF7C0740Q35681039-F1D79499-2A4B-4938-B236-45DE31613E2DQ35971342-C4A39211-7AFA-438E-BD07-35F89F94D04DQ35972056-1DDAAF51-98C5-4447-B38A-859FA47D12EFQ36202013-14D9192A-55CA-4BDC-814A-28DBEA4CB3E4Q36491681-BBF16529-8EA5-4343-B6F5-D339CEAB0A44Q36499640-B92083BE-B79A-454A-8607-7001D8F62544Q36633134-B40E0512-1B04-44B5-97A1-0DD76FD92D52Q36770986-D4220FB6-B8C2-4B41-9658-25275B97EE20Q36854132-AD7FDC27-60C2-4B8E-BD9C-83E79890437DQ36920058-17A3BBD2-9BA3-4431-91F1-AC52A1F047C7Q37385678-CACCDFF0-787B-46EC-AA64-32123D198E43Q37398388-5C86B179-0CD3-4F32-A123-9DEAC2DD7CFFQ37514014-24F2B361-73CF-40CE-855B-D8EF95F26B50Q37570882-B8A15762-79E6-46F5-8B7E-B37150529BB9Q37765941-2F8C3AAB-1BB0-4C9A-9A6C-5AD11C7D7473Q37795699-54436123-D70B-4985-B730-07469A08D539Q37905899-1BB8F8DA-1009-4E21-AF0D-0AF5C2C19A8CQ38154864-DBD2BCAE-8CC9-4665-80E9-15F11D75E5C0Q39846076-877100A8-DF80-415E-B842-35F7311CB120Q40307566-1E3C9A2E-9A0B-48F8-8B44-C9C4A2B8BC2D
P2860
The effect of estrogen replacement on early Parkinson's disease.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The effect of estrogen replacement on early Parkinson's disease.
@ast
The effect of estrogen replacement on early Parkinson's disease.
@en
type
label
The effect of estrogen replacement on early Parkinson's disease.
@ast
The effect of estrogen replacement on early Parkinson's disease.
@en
prefLabel
The effect of estrogen replacement on early Parkinson's disease.
@ast
The effect of estrogen replacement on early Parkinson's disease.
@en
P2093
P356
P1433
P1476
The effect of estrogen replacement on early Parkinson's disease.
@en
P2093
Bressman S
Gordon-Elliott J
Saunders HR
Saunders-Pullman R
P304
P356
10.1212/WNL.52.7.1417
P407
P50
P577
1999-04-01T00:00:00Z